Literature DB >> 21161276

Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus.

Luciana T Zimmermann1, Evelize Folly, Marta T Gomes, Daniela S Alviano, Celuta S Alviano, Fernando C Silva-Filho, Geórgia C Atella, Angela H Lopes.   

Abstract

We investigated the effects of platelet-activating factor (PAF) on the interaction of Trypanosoma cruzi with Rhodnius prolixus. The parasites (epimastigotes) were treated with PAF and/or WEB 2086 (PAF antagonist) for 1 h prior to the interaction experiments. PAF stimulated both in vivo and ex vivo interactions between T. cruzi and R. prolixus while WEB 2086 abrogated these effects. PAF-treated epimastigotes also showed an increase in surface negativity and in the amount of surface sialic acid. Neither of these effects was observed when the epimastigotes were treated with neuraminidase following PAF treatment. In the ex vivo interaction experiments, the number of epimastigotes bound to the midguts of the insects was reduced when the epimastigotes had been treated with neuraminidase. We conclude that PAF modulates the interaction of T. cruzi with R. prolixus by altering the amount of sialyl residues at the surface of the parasite.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161276     DOI: 10.1007/s00436-010-2194-2

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  39 in total

1.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.

Authors:  E P CAMARGO
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1964 May-Jun       Impact factor: 1.846

2.  The surface charge of Trypanosoma cruzi: analysis using cell electrophoresis, lectins and ultrastructural cytochemistry.

Authors:  T Souto-Padrón; W De Souza
Journal:  J Submicrosc Cytol       Date:  1986-10

Review 3.  Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases.

Authors:  Laura J Edwards; Cris S Constantinescu
Journal:  Inflamm Allergy Drug Targets       Date:  2009-07

4.  WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph.

Authors:  Evandro M M Machado; Patrícia Azambuja; Eloi S Garcia
Journal:  J Insect Physiol       Date:  2006-04-05       Impact factor: 2.354

Review 5.  Chagas disease and stroke.

Authors:  Francisco Javier Carod-Artal; Joaquim Gascon
Journal:  Lancet Neurol       Date:  2010-05       Impact factor: 44.182

Review 6.  Platelet-activating factor receptor: gene expression and signal transduction.

Authors:  T Izumi; T Shimizu
Journal:  Biochim Biophys Acta       Date:  1995-12-07

Review 7.  The development of Trypanosoma cruzi in triatominae.

Authors:  A H Kollien; G A Schaub
Journal:  Parasitol Today       Date:  2000-09

8.  A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.

Authors:  S Schenkman; M S Jiang; G W Hart; V Nussenzweig
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

9.  Incorporation of sialic acid into Trypanosoma cruzi macromolecules. A proposal for a new metabolic route.

Authors:  J O Previato; A F Andrade; M C Pessolani; L Mendonça-Previato
Journal:  Mol Biochem Parasitol       Date:  1985-06       Impact factor: 1.759

10.  Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi.

Authors:  C O Rodrigues; P M Dutra; T Souto-Padrón; R S Cordeiro; A H Lopes
Journal:  Biochem Biophys Res Commun       Date:  1996-06-25       Impact factor: 3.575

View more
  1 in total

1.  Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.

Authors:  Felipe Gazos-Lopes; Mauricio M Oliveira; Lucas V B Hoelz; Danielle P Vieira; Alexandre F Marques; Ernesto S Nakayasu; Marta T Gomes; Nasim G Salloum; Pedro G Pascutti; Thaïs Souto-Padrón; Robson Q Monteiro; Angela H Lopes; Igor C Almeida
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.